Skip to content
healthcare.dev

Jentadueto

NDC 0597-0147, linagliptin and metformin hydrochloride, tablet, film coated, from Boehringer Ingelheim Pharmaceuticals, Inc..

Product NDC
0597-0147
Status
Listed
Labeler
Boehringer Ingelheim Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA201281
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0597-0147 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LINAGLIPTIN2.5 mg/1
  • METFORMIN HYDROCHLORIDE850 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
0597-0147-1800597014718180 TABLET, FILM COATED in 1 BOTTLE (0597-0147-18)
0597-0147-600059701476060 TABLET, FILM COATED in 1 BOTTLE (0597-0147-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f6dd9b86-0d18-95d4-2bc7-05591bfdd597
  • NADAC price for package 00597014718

    GET /v1/drugs/nadac/00597014718
  • NADAC price for package 00597014760

    GET /v1/drugs/nadac/00597014760

Use it

Look up 0597-0147 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0597-0147 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0597-0147. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.